First-line triplet chemotherapy plus bevacizumab (FIr-B/FOx) can improve efficacy of metastatic colorectal cancer (MCRC), KRAS wild-type and mutant. Prognostic relevance of KRAS genotype was evaluated in patients unfit for FIr-B/FOx, treated with conventional medical treatments. Consecutive MCRC patients not eligible for FIr-B/FOx regimen due to age (≥75 years) and/or comorbidities were treated...

Funding: This study was funded by a grant from the Office of Consumer Affairs at Industry Canada. The sponsor played no role in gathering or analyzing the data. The authors had full control over all contents of the paper. communicating information about health treatments. By informing the public about new research findings, they can affect how medical treatments are perceived 1 and, in so doing...

The more that advances in the medical field are capable of targeted treatments, imaging should be tailored to patients [...]

The problem of finding treatments for patients diagnosed with multiple diseases (i.e. a comorbidity) is an important research topic in the medical literature. In this paper, we propose a new data driven approach to recommend treatments for these comorbidities using wordbased and phrase-based alignment methods. The most popular methods currently rely on combining specific information from indivi...

Complementary medicines, traditional remedies and home cures for medical ailments are used extensively world-wide, representing more than US$60 billion sales in the global market. With serious doubts about the efficacy and safety of many treatments, the industry remains steeped in controversy. Little is known about factors affecting the prevalence of efficacious and non-efficacious self-medicat...